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FIRST CLINICAL CASE REPORTRelapsing sepsis episodes of Escherichia coli with CTX-M ESBL or
derepressed ampC genes in a patient with chronic autoimmune
pancreatitis complicated by IgG4 hypergammaglobulinaemiaT. Tuuminen1,2, M. Österblad3, S. Hämäläinen4 and R. Sironen5,6,7
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Medicine and 7) Biocenter Kuopio and Cancer Center of Easter Finland, University of Eastern Finland, Kuopio, FinlandAbstractBloodstream recurrent infections have been reported for a variety of opportunistic bacteria. These are often either catheter related or are
caused by indwelling devices. A case of relapsing sepsis with two Escherichia coli strains carrying extended-spectrum β-lactamase and
derepressed ampC genes is reported. The patient had seven episodes of bloodstream infections within 1 year and was diagnosed with
chronic autoimmune pancreatitis and IgG4 hypergammaglobulinaemia. Abscesses were found in his spleen and pancreas cauda, which was
ﬁnally resected. Relapses of bacteraemia with resistant enterobacteria should be considered during perioperative protection. Surgical
removal of the infective focus could be curative.
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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E-mail: tamara.tuuminen@islab.ﬁIntroductionRecurrent bloodstream infections are either reinfections or
relapses caused by the same strain. Bloodstream recurrent in-
fections have been reported for a great variety of opportunistic
bacteria, with coagulase-negative staphylococci being the most
common [1]. The majority of the relapsing sepsis infections are
either catheter related or are caused by indwelling devices that
serve as an excellent solid phase for sticky bioﬁlms, the source
for transient bacterial translocation into the vessel lumen. Re-
lapsing Escherichia coli bacteraemias have also been describedw Microbe and New Infect 2016; 9: 50–53
w Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice
p://dx.doi.org/10.1016/j.nmni.2015.10.013[2–5]. Molecular ﬁngerprinting [2,3] as well as biochemical
analysis and serotyping [4] have shown that the majority of the
sepsis episodes might be caused by the same strain even when
adequate antimicrobial therapy is provided. Taking into account
the multistrain and multispecies complexity of bioﬁlm, it re-
mains unclear why sepsis episodes are often caused by exactly
the same strain and what kind of “leads” this strain may have
compared to other “inhabitants” of the bioﬁlm ecosystem.
Here we report a case of recurrent E. coli sepsis. Altogether,
the patient experienced seven episodes of E. coli bacteraemia in
just over a year. All the episodes can be considered as relapses
caused by the extended-spectrum β-lactamase (ESBL) strain or
by the AmpC hyperproducer. Finally, the focus of these
bloodborne infections was found in his spleen and pancreas
cauda, which was resected. Of interest, the underlying disease,
autoimmune pancreatitis of type 1 with IgG4 hyper-
globulinaemia, had probably contributed to the formation of the
cyst that harboured infection.European Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 2. Antibiotic treatment of patient in periods between
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Duration of administration (days)




















CIP, ciproﬂoxacin; CXM, cefuroxime; ETP, ertapenem; MEM, meropenem; TZP,
piperacillin–tazobactam; VAN, vancomycin.A 47-year-old man came to Finland as a refugee from Southeast
Asia. In the immigration health inspection, he was diagnosed
with a Toxocara canis infection and treated with mebendazole.
Soon after arrival, he complained of epigastric pain and fever; he
was diagnosed with acute pancreatitis, which was treated
conservatively. After this episode, the patient gave up alcohol
completely. Pancreatitis episodes, often complicated with sep-
ticaemias, recurred several times during the following years.
Radiologic ﬁndings conﬁrmed chronic pancreatitis with calciﬁ-
cations. Papillotomy, dilatation and stent insertion into the
strictured ductus Wirsung were performed. Written informed
consent was obtained from the patient.
Three years after the ﬁrst pancreatic episode, the patient
was hospitalized again for fever and multiple liver abscesses.
Abscesses were also found in the spleen and pancreas. Blood
cultures revealed Lactococcus species. Drainage of abscesses was
not feasible because of the small size of the multiple abscesses
and the challenging anatomic site. An infection of the pancreatic
duct stent was suspected, and the stent was removed. ESBL-
producing Escherichia coli septicaemia complicated the surgical
intervention. The condition progressed despite long-term
antimicrobial therapy.
The patient was negative for parasitic infection, HIV, and
Echinococcus serology. Instead, Toxocara canis serology remained
positive, compatible with his early infection. During the
following months, the patient was hospitalized several times for
recurrent pancreatitis and relapsing episodes of sepsis. The
laboratory data on the blood culture isolates are presented in
Table 1.
Abscess formation continued even though the patient
received various antimicrobials (Tables 2 and 3). Eventually
cholecystectomy, splenectomy and a partial pancreatic resec-
tion were considered. In addition to resection of the pancreatic
cauda, the enlarged spleen was removed, and cholecystectomy
was performed. Histopathologic examination of the pancreas
revealed extensive ﬁbrosis, multiple cysts (1–2 cm in diameter)TABLE 1. Characteristics of isolated Escherichia coli strains from bl
Sepsis episode Organism
Antimicrobial susceptibility (mm) (interpre
TZP CIP TOB SXT
April 2013 ESBL E. coli 22 (I) 6 (R) 20 (S) 6 (R)
May 2013 ESBL E. coli 22 (I) 6 (R) 20 (S) 6 (R)
August 2013 AmpC E. coli 24 (S) 35 (S) 22 (S) 27 (S)
November 2013 AmpC E. coli 24 (S) 35 (S) 22 (S) 27 (S)
March 2014 AmpC E. coli 24 (S) 35 (S) 22 (S) 27 (S)
March 2014 ESBL E. coli 25 (I) 6 (R) 20 (S) 6 (R)
May 2014 ESBL E. coli 25 (I) 6 (R) 20 (S) 6 (R)
CAZ, ceftazidime; CIP, ciproﬂoxacin; CRO, ceftriaxone; CXM, cefuroxime; ESBL, extended-
determined; NET, netilmicin; R, resistant; S, susceptible; TOB, tobramycin; TZP, piperacillin
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiand inﬂammatory cells such as neutrophils, macrophages, lym-
phocytes and plasma cells that were partly immunopositive for
IgG4. Histology revealed no microorganisms. The hilum of the
spleen revealed purulent inﬂammation, but the splenic paren-
chyma and gallbladder were structurally normal. Computed
tomographic scan revealed numerous degenerative cystic le-
sions in the spleen that most probably had formed as a result of
prolonged bacterial infection (Fig. 1). A pseudocyst ﬁlled with a
grey ﬂuid was found between the pancreatic cauda and the
spleen. ESBL E. coli was isolated from the ﬂuid. All other tissue
cultures were negative in bacteriologic, mycobacteriologic,
virologic and parasitologic examinations. These ﬁndings ﬁnally
conﬁrmed suspected end-stage chronic autoimmune pancrea-
titis associated with the IgG4 syndrome [6]. During convales-
cence, the patient had a relapse of ESBL E. coli sepsis but
recovered completely.
The strains were tested for β-lactamase genes as previously
described [7]. All 3 ESBL isolates harboured a CTX-M gene.
Three other E. coli isolates (Table 1) had an AmpC phenotype
and were negative for ampC genes (CIT, DHA, MOX, FOX, EBC,ood culture samples and pancreatic cyst
tation)
ETP MEM NET ATM CRO CXM CAZ
30 (S) 30 (S) 20 (S) 21 (I) ND ND ND
30 (S) 30 (S) 20 (S) 21 (I) ND ND ND
28 (S) 29 (S) ND 23 (I) 27 (S) 18 (S) 21 (I)
28 (S) 29 (S) ND 23 (I) 27 (S) 18 (S) 21 (I)
28 (S) 29 (S) ND 23 (I) 27 (S) 18 (S) 21 (I)
27 (S) 30 (S) ND 18 (R) ND ND ND
27 (S) 30 (S) ND 18 (R) ND ND ND
spectrum β-lactamase; ETP, ertapenem; I, intermediate; MEM, meropenem; ND, not
–tazobactam.
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CXM Cefuroxime 1.5 g × 3 iv
TZP Piperacillin–tazobactam 4 g × 3 iv
MEM Meropenem 1 g × 3 iv
ETP Ertapenem 1 g × 1 iv, po
VAN Vancomycin 1 g × 2 iv
CIP Ciproﬂoxacin 500 mg × 2 po
iv, intravenous; po, by mouth.
FIG. 1. Radiologic description of computed tomographic scan of the
body (shortened). Liver is diffusely fatty without clear features of
cirrhosis. Spleen is enlarged, with craniocaudal dimension of 14 cm. In
hilus region there are small ﬁngerlike liquid retentions that could be
traits of abscesses or pseudocysts. Prominent lymphatic node is evident
between ventricle and spleen, with dimension of 11 mm. Corpus and
cauda of pancreas are atrophic; ducts are widened, maximum 7–8 mm
at corpus region. Abundance of calciﬁed lesions in caput is compatible
with chronic pancreatitis. Region of abscesses in spleen is circled.
Breathing artifact is evident in abdominal region.
FIG. 2. Pulsed-ﬁeld gel electrophoresis of strains. Lanes 1, 5 and 10,
control strain; lanes 2–4, 2 AmpC overproducer; lanes 6–9, ESBL
strain. ESBL, extended-spectrum β-lactamase.
52 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNIACC), thus apparently overproducing the chromosomal AmpC.
In order to investigate the clonality of the strains, we per-
formed molecular typing. The culture isolates were analysed
with pulsed-ﬁeld gel electrophoresis using a protocol based on
PulseNet for E. coli (http://www.cdc.gov/pulsenet/pathogens/
ecoli.html). Brieﬂy, genomic DNA was digested with XbaI
(New England Biolabs), and separated in a Chef DR III (Bio-
Rad). Banding patterns were interpreted using the criteria of
Tenover et al. [8]. The ESBL isolates were found to be the same
strain (one- to two-band differences in the banding patterns).
The AmpC overproducers were also similar (a one-band dif-
ference in one isolate); however, they were different from the
ESBL clone (Fig. 2).
Soon after the surgical intervention, our patient experienced
a new episode of ESBL sepsis—a complication that might haveNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licebeen avoided if previous bacteriologic data had been taken into
account so perioperative carbapenem prophylaxis could have
been implemented.DiscussionThe reported case emphasizes that the primary prevention of
bloodstream relapses caused by Gram-negative bacteria is the
surgical elimination of the focus of infection. Being encapsulated
in a cyst, the bacteria are well protected against the bactericidal
action of antimicrobials even in organs with good vasculariza-
tion such as the pancreas.
Relapses of bacteraemia with enterobacteria can occur in
patients with underlying gastrointestinal or autoimmune dis-
orders, as in our case. These episodes can be caused by
resistant bacteria, which should be considered duringEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 50–53
nses/by-nc-nd/4.0/)
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